Propylthiouracil

What is propylthiouracil?

Propylthiouracil — almost always abbreviated PTU — is an oral antithyroid medication used to treat Hyperthyroidism, including Graves Disease. It belongs to the same drug class as Methimazole (the thionamides) and works by reducing the thyroid gland's production of T4 and T3.

In the U.S., methimazole is the first-line antithyroid medication for most adults because it is more potent and has a lower risk of liver injury. PTU is reserved for specific situations — most importantly the first trimester of pregnancy, thyroid storm, and patients who cannot tolerate methimazole.

How does propylthiouracil work?

PTU has two mechanisms. First, like methimazole, it blocks thyroid peroxidase (TPO), the enzyme that builds thyroid hormone inside the gland. This gradually lowers Free T4 and Free T3 over weeks. Second, at higher doses, PTU also blocks the conversion of T4 to T3 in peripheral tissues, which can rapidly reduce active hormone levels. That second mechanism is why PTU is favored in thyroid storm, the life-threatening extreme of hyperthyroidism.

Because PTU has a shorter half-life than methimazole, it is usually taken three times a day rather than once.

When is it prescribed?

PTU is typically reserved for:

• First-trimester pregnancy in women with hyperthyroidism, where methimazole carries a small but documented risk of specific birth defects.
• Thyroid storm, in combination with Beta Blockers, iodine, and steroids.
• Patients with significant intolerance or allergy to methimazole.
• Short-term use in pre-operative preparation when methimazole is not an option.

Many clinicians switch from PTU back to methimazole at the start of the second trimester to reduce ongoing liver risk.

Patient considerations

Most patients tolerate PTU well, but it carries the same general risks as other antithyroid drugs and a few that are specific to it:

• Liver toxicity — including rare but serious liver failure. PTU carries a black-box warning for this. Baseline and follow-up liver function tests are essential, and any dark urine, jaundice, severe abdominal pain, or unusual fatigue should prompt urgent evaluation.
• Agranulocytosis — a sudden drop in white blood cells, usually in the first three months. Unexplained fever, severe sore throat, or mouth ulcers warrant a same-day CBC.
• ANCA-associated vasculitis — uncommon but well-documented with longer-term PTU use.
• Rash, joint aches, GI upset.

PTU is not appropriate for routine outpatient hyperthyroidism in non-pregnant adults when methimazole is an option, severe pre-existing liver disease, prior PTU-induced agranulocytosis, or as a substitute for definitive treatment when long-term medical management has failed.

At Modern Thyroid Clinic, antithyroid medication is paired with a broader strategy: supporting nutrition, addressing autoimmune triggers, calming stress physiology, and protecting the patient's overall thyroid future, not just suppressing the immediate flare.